10.04
price down icon1.08%   -0.11
after-market アフターアワーズ: 10.04
loading
前日終値:
$10.15
開ける:
$10.15
24時間の取引高:
5.27M
Relative Volume:
0.93
時価総額:
$7.27B
収益:
$125.68M
当期純損益:
$4.81B
株価収益率:
1.777
EPS:
5.65
ネットキャッシュフロー:
$-781.21M
1週間 パフォーマンス:
-1.47%
1か月 パフォーマンス:
-6.95%
6か月 パフォーマンス:
-13.60%
1年 パフォーマンス:
-4.02%
1日の値動き範囲:
Value
$10.01
$10.32
1週間の範囲:
Value
$9.895
$10.32
52週間の値動き範囲:
Value
$8.73
$13.05

Roivant Sciences Ltd Stock (ROIV) Company Profile

Name
名前
Roivant Sciences Ltd
Name
セクター
Healthcare (1155)
Name
電話
441-295-5950
Name
住所
CLARENDON HOUSE, 2 CHURCH STREET, HAMILTON HM11
Name
職員
908
Name
Twitter
Name
次回の収益日
2025-02-10
Name
最新のSEC提出書
Name
ROIV's Discussions on Twitter

ROIV を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Biotechnology icon
ROIV
Roivant Sciences Ltd
10.04 7.27B 125.68M 4.81B -781.21M 5.65
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
477.52 127.47B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
561.49 62.43B 14.20B 4.41B 3.54B 38.28
Biotechnology icon
ARGX
Argen X Se Adr
595.70 37.03B 2.19B 833.04M -1.28B 12.71
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
232.75 31.06B 2.25B -278.16M -42.59M -2.17
Biotechnology icon
ONC
Beigene Ltd Adr
229.22 26.16B 3.81B -644.79M -669.77M -6.24

Roivant Sciences Ltd Stock (ROIV) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2024-02-15 開始されました Wolfe Research Outperform
2024-01-05 開始されました Piper Sandler Overweight
2023-12-12 開始されました Deutsche Bank Buy
2023-10-17 開始されました Guggenheim Buy
2023-06-08 開始されました BofA Securities Neutral
2022-10-27 開始されました JP Morgan Overweight
2022-05-23 開始されました SVB Leerink Outperform
2022-04-29 開始されました Cantor Fitzgerald Overweight
2021-12-15 開始されました Goldman Buy
2021-11-08 開始されました H.C. Wainwright Buy
2021-10-28 開始されました Citigroup Buy
2021-10-26 開始されました Cowen Outperform
2021-10-26 開始されました Jefferies Buy
2021-10-26 開始されました Truist Buy
すべてを表示

Roivant Sciences Ltd (ROIV) 最新ニュース

pulisher
06:31 AM

Roivant Tightens Leadership Grip On Immunovant, Narrows Near-Term IMVT-1402 Focus - insights.citeline.com

06:31 AM
pulisher
12:26 PM

Cantor Fitzgerald maintains overweight on Roivant Sciences stock By Investing.com - Investing.com South Africa

12:26 PM
pulisher
07:50 AM

Immunovant Announces Next Phase Of Growth With Roivant Including Changes To Its Leadership Team And Additional Indications - marketscreener.com

07:50 AM
pulisher
Apr 18, 2025

When (ROIV) Moves Investors should Listen - news.stocktradersdaily.com

Apr 18, 2025
pulisher
Apr 11, 2025

Is Roivant Sciences Ltd. (ROIV) the Top Healthcare Stock to Buy According to Billionaire David Einhorn? - Yahoo Finance

Apr 11, 2025
pulisher
Apr 10, 2025

Roivant Sciences Ltd. (ROIV): Among the Best Low Priced Growth Stocks to Invest In - Insider Monkey

Apr 10, 2025
pulisher
Apr 07, 2025

Immunovant, Roivant slip after trial data for autoimmune disorder therapy - MSN

Apr 07, 2025
pulisher
Apr 02, 2025

Knott David M Jr Decreases Stock Holdings in Roivant Sciences Ltd. (NASDAQ:ROIV) - MarketBeat

Apr 02, 2025
pulisher
Apr 02, 2025

KLP Kapitalforvaltning AS Invests $918,000 in Roivant Sciences Ltd. (NASDAQ:ROIV) - MarketBeat

Apr 02, 2025
pulisher
Mar 31, 2025

ROIV stock touches 52-week low at $9.96 amid market fluctuations By Investing.com - Investing.com South Africa

Mar 31, 2025
pulisher
Mar 31, 2025

ROIV stock touches 52-week low at $9.96 amid market fluctuations - Investing.com Australia

Mar 31, 2025
pulisher
Mar 29, 2025

Is Roivant Sciences (ROIV) the Best Mid Cap Biotech Stock to Buy? - Insider Monkey

Mar 29, 2025
pulisher
Mar 29, 2025

Loomis Sayles & Co. L P Has $43.43 Million Stock Holdings in Roivant Sciences Ltd. (NASDAQ:ROIV) - MarketBeat

Mar 29, 2025
pulisher
Mar 28, 2025

Insider Selling: Roivant Sciences Ltd. (NASDAQ:ROIV) COO Sells 315,522 Shares of Stock - MarketBeat

Mar 28, 2025
pulisher
Mar 25, 2025

Is Roivant Sciences Ltd. (NASDAQ:ROIV) One of The Best Stocks to Buy According to Billionaire David Einhorn? - Insider Monkey

Mar 25, 2025
pulisher
Mar 25, 2025

Roivant Sciences president Eric Venker sells shares worth $8.19 million By Investing.com - Investing.com UK

Mar 25, 2025
pulisher
Mar 24, 2025

Roivant Sciences president Eric Venker sells shares worth $8.19 million - Investing.com

Mar 24, 2025
pulisher
Mar 23, 2025

(ROIV) Trading Advice - news.stocktradersdaily.com

Mar 23, 2025
pulisher
Mar 20, 2025

Roivant Sciences finalizes consulting agreement with former officer - Investing.com India

Mar 20, 2025
pulisher
Mar 19, 2025

Roivant Phase III Batoclimab Trial Is Positive, But No Filing Planned - insights.citeline.com

Mar 19, 2025
pulisher
Mar 19, 2025

Roivant Sciences Says Phase 3 MG Study Meets Primary Endpoint -March 19, 2025 at 08:24 am EDT - Marketscreener.com

Mar 19, 2025
pulisher
Mar 19, 2025

Roivant Sciences Announces Positive Results for Batoclimab Studies - TipRanks

Mar 19, 2025
pulisher
Mar 18, 2025

Critical Clinical Data Coming: Roivant's Dual Breakthrough Results in MG and CIDP Studies - Stock Titan

Mar 18, 2025
pulisher
Mar 12, 2025

(ROIV) Trading Signals - Stock Traders Daily

Mar 12, 2025
pulisher
Mar 12, 2025

Wall Street Analysts Believe Montes Archimedes Acquisition (ROIV) Could Rally 60%: Here's is How to Trade - Nasdaq

Mar 12, 2025
pulisher
Mar 11, 2025

Roivant at Leerink’s Conference: Strategic Insights and Developments By Investing.com - Investing.com Australia

Mar 11, 2025
pulisher
Mar 07, 2025

Does Roivant (ROIV) Offer an Attractive Risk Reward Opportunity? - Insider Monkey

Mar 07, 2025
pulisher
Mar 04, 2025

Genevant and Arbutus initiate patent lawsuit against Moderna - The Pharma Letter

Mar 04, 2025
pulisher
Mar 04, 2025

10 Cash-Rich Mid Cap Stocks To Buy Now - Insider Monkey

Mar 04, 2025
pulisher
Mar 03, 2025

Roivant Sciences Ltd. (ROIV): Among the Cash-Rich Mid Cap Stocks to Buy Now - Insider Monkey

Mar 03, 2025
pulisher
Mar 02, 2025

Roivant Sciences Ltd. (NASDAQ:ROIV) Shares Bought by New York State Common Retirement Fund - Defense World

Mar 02, 2025
pulisher
Mar 01, 2025

Trend Tracker for (ROIV) - Stock Traders Daily

Mar 01, 2025
pulisher
Feb 28, 2025

Principal Financial Group Inc. Lowers Holdings in Roivant Sciences Ltd. (NASDAQ:ROIV) - MarketBeat

Feb 28, 2025
pulisher
Feb 27, 2025

Handelsbanken Fonder AB Trims Position in Roivant Sciences Ltd. (NASDAQ:ROIV) - MarketBeat

Feb 27, 2025
pulisher
Feb 27, 2025

Net worth of Vivek Ramaswamy: Roviant Sciences founder who is running for Ohio governor - Times of India

Feb 27, 2025
pulisher
Feb 25, 2025

Early Warning Report Issued Pursuant to National Instrument 62‐103: Roivant announces Resignation and Replacement of Arbutus Board - The Manila Times

Feb 25, 2025
pulisher
Feb 25, 2025

Early Warning Report Issued Pursuant to National Instrument 62?103: Roivant announces Resignation and Replacement of Arbutus Board - Lelezard

Feb 25, 2025
pulisher
Feb 25, 2025

Key milestones in Vivek Ramaswamy’s academic journey: From being a Valedictorian to a member of Harvard P - Times of India

Feb 25, 2025
pulisher
Feb 24, 2025

Roivant Sciences president Eric Venker sells $1.07 million in shares - Investing.com India

Feb 24, 2025
pulisher
Feb 21, 2025

Roivant Sciences appoints new Principal Accounting Officer By Investing.com - Investing.com South Africa

Feb 21, 2025
pulisher
Feb 21, 2025

Roivant Sciences appoints new Principal Accounting Officer - Investing.com

Feb 21, 2025
pulisher
Feb 21, 2025

Roivant Sciences Appoints New Chief Accounting Officer - TipRanks

Feb 21, 2025

Roivant Sciences Ltd (ROIV) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$20.07
price up icon 0.15%
$69.51
price down icon 4.32%
$32.19
price down icon 1.26%
$25.22
price up icon 2.48%
$101.81
price up icon 3.09%
biotechnology ONC
$229.22
price down icon 0.76%
大文字化:     |  ボリューム (24 時間):